CPC Subgroup
C12Y 301/07 Diphosphoric monoester hydrolases (3.1.7)
Full Title
Hydrolases acting on ester bonds (3.1) > Diphosphoric monoester hydrolases (3.1.7)
Filing statistics
CPC C12Y 301/07 belongs to the parent subclass C12Y, which recorded 144,590 patent applications worldwide between 2013 and 2023. Annual filings grew from 9,773 in 2013 to 11,938 in 2023 (+22%), peaking at 15,970 applications in 2021. The most active applicants in class C12 are HARVARD UNIVERSITY (8,321 applications), CHINESE ACADEMY OF SCIENCES (7,486 applications) and UNIVERSITY OF CALIFORNIA (7,320 applications).
Source: EPO PATSTAT, worldwide filings
11 direct subcodes
Child Classifications
Navigate with arrow keys, Enter to open
- C12Y 301/07001 Prenyl-diphosphatase (3.1.7.1)
- C12Y 301/07002 Guanosine-3',5'-bis(diphosphate) 3'-diphosphatase (3.1.7.2)
- C12Y 301/07003 Monoterpenyl-diphosphatase (3.1.7.3)
- C12Y 301/07004 Sclareol cyclase (3.1.7.4)
- C12Y 301/07005 Geranylgeranyl diphosphate diphosphatase (3.1.7.5)
- C12Y 301/07006 Farnesyl diphosphatase (3.1.7.6)
- C12Y 301/07007 Drimenol cyclase (3.1.7.7)
- C12Y 301/07008 Tuberculosinol synthase (3.1.7.8)
- C12Y 301/07009 Isotuberculosinol synthase (3.1.7.9)
- C12Y 301/0701 (13E)-Labda-7,13-dien-15-ol synthase (3.1.7.10)
- C12Y 301/07011 Geranyl diphosphate diphosphatase (3.1.7.11)
Top Applicants
Top 10 applicants by patent filingsfor class C12, 2013–2023, worldwide · Source: EPO PATSTAT
- HARVARD UNIVERSITY US 8,321
- CHINESE ACADEMY OF SCIENCES 7,486
- UNIVERSITY OF CALIFORNIA US 7,320
- REGENERON PHARMACEUTICALS US 5,003
- INSERM (INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE) FR 4,292
- UNIVERSITY OF PENNSYLVANIA US 4,213
- CNRS (CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE) FR 4,113
- JIANGNAN UNIVERSITY 3,961
- ROCHE CH 3,792
- ILLUMINA US 3,692